FLECTOR Drug Patent Profile

✉ Email this page to a colleague

When do Flector patents expire, and what generic alternatives are available?

Flector is a drug marketed by Ibsa and is included in one NDA.

The generic ingredient in FLECTOR is diclofenac epolamine. There are forty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the diclofenac epolamine profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for FLECTOR?
What are the global sales for FLECTOR?
What is Average Wholesale Price for FLECTOR?

Summary for FLECTOR

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	7
Raw Ingredient (Bulk) Api Vendors:	25
Clinical Trials:	5
Patent Applications:	103
Drug Prices:	Drug price information for FLECTOR
What excipients (inactive ingredients) are in FLECTOR?	FLECTOR excipients list
DailyMed Link:	FLECTOR at DailyMed

Drug patent expirations by year for FLECTOR

Recent Clinical Trials for FLECTOR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Fidia Farmaceutici s.p.a.	Phase 3
Fidia Farmaceutici s.p.a.	Phase 1
IBSA Institut Biochimique SA	Phase 4

See all FLECTOR clinical trials

Pharmacology for FLECTOR

Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors
Physiological Effect	Decreased Prostaglandin Production

Paragraph IV (Patent) Challenges for FLECTOR

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
FLECTOR	Topical Patch	diclofenac epolamine	1.3%	021234	1	2015-06-26

US Patents and Regulatory Information for FLECTOR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ibsa	FLECTOR	diclofenac epolamine	SYSTEM;TOPICAL	021234-001	Jan 31, 2007		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for FLECTOR

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ibsa	FLECTOR	diclofenac epolamine	SYSTEM;TOPICAL	021234-001	Jan 31, 2007	⤷ Sign Up	⤷ Sign Up
Ibsa	FLECTOR	diclofenac epolamine	SYSTEM;TOPICAL	021234-001	Jan 31, 2007	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for FLECTOR

See the table below for patents covering FLECTOR around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Canada	2121065	PREPARATION POUR PLATRE EXTERNE ANTI-INFLAMMATOIRE ET ANALGESIQUE (EXTERNAL ANTI-INFLAMMATORY AND ANALGESIC PLASTER PREPARATION)	⤷ Sign Up
Italy	1228242	SALE DEL DICLOFENAC CON IDROSSIETILPIRROLIDINA E COMPOSIZIONI FARMACEUTICHE CHE LO CONTENGONO	⤷ Sign Up
Italy	8622320		⤷ Sign Up
European Patent Office	0271709	SALT OF DICLOFENAC WITH A CYCLIC ORGANIC BASE AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN IT	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration